age recommendation for prevnar
On June 20, 2012, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent. pneumococcal conjugate vaccine (PCV13; Prevnar) for adults aged â¥ 19 years with immunocompromising conditions, functional or anatomic asplenia, cerebrospinal fluid (CSF) leaks, or cochlear implants.